GS
Gunjan Shukla
About Gunjan Shukla
Data last updated:
Gunjan Shukla is a Whole-Time Director at Medwock Pharmaceuticals Private Limited (since 2019) and Director at Symvivo Pharmaceuticals Private Limited (since 2025). The companies operate in Pharma. The largest current company by reported revenue is Medwock Pharmaceuticals Private Limited at ₹4.3 Lakh (FY 2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 18 Apr 2019 | 2019 | ₹4.3 Lakh (FY 2020) | Active | |
| Director | 15 Jul 2025 | 2025 | Active |
Board colleagues of Gunjan Shukla
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amit Kumar Sharma | 08425410 | Medwock Pharmaceuticals Private Limited | Whole-Time Director |
| Reeta Devi | 08425412 | Medwock Pharmaceuticals Private Limited | Whole-Time Director |
| Soni Jha | 08506076 | Medwock Pharmaceuticals Private Limited | Additional Director |
| Vivek Rawat | 11195320 | Symvivo Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gunjan Shukla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gunjan Shukla
Gunjan Shukla currently holds 2 directorships: Medwock Pharmaceuticals Private Limited (Whole-Time Director, since 18 Apr 2019, revenue ₹4.3 Lakh (FY 2020)); Symvivo Pharmaceuticals Private Limited (Director, since 15 Jul 2025).
Gunjan Shukla was first appointed on 18 Apr 2019 as Whole-Time Director at Medwock Pharmaceuticals Private Limited. The most recent appointment on record is 15 Jul 2025 at Symvivo Pharmaceuticals Private Limited.
The current boards of Gunjan Shukla's companies include Amit Kumar Sharma (Medwock Pharmaceuticals Private Limited), Reeta Devi (Medwock Pharmaceuticals Private Limited), Soni Jha (Medwock Pharmaceuticals Private Limited), Vivek Rawat (Symvivo Pharmaceuticals Private Limited).